Compartmentalised screening by microfluidic control

Patent metadata

Field	Value
Publication number	US-10371699-B2
Application number	US-201615331445-A
Country	US
Kind code	B2
Filing date	Oct 21, 2016
Priority date	Oct 12, 2004
Publication date	Aug 6, 2019
Grant date	Aug 6, 2019

Abstract

The invention describes a method for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, comprising the steps of: a) compartmentalizing the compounds into microcapsules together with the target, such that only a subset of the repertoire is represented in multiple copies in any one microcapsule; and b) identifying the compound which binds to or modulates the activity of the target; wherein at least one step is performed under microfluidic control. The invention enables the screening of large repertoires of molecules which can serve as leads for drug development.

First claim

The invention claimed is:

1. A method for screening a repertoire of compounds for a compound having a desired activity, comprising the steps of:
(a) providing an aqueous fluid comprising the repertoire of compounds;
(b) compartmentalising the repertoire of compounds into microcapsules by partitioning the aqueous fluid with an immiscible fluid as the aqueous fluid is flowing through a microfluidic channel, such that only a subset of the repertoire is represented in multiple copies in any one microcapsule and wherein each microcapsule comprises a target cell;
(c) conducting a reaction involving a molecule associated with the target cell, wherein the compound has an effect on the reaction; and
(d) detecting a product of the reaction to identify a microcapsule containing the compound having the desired activity.

2. The method of claim 1 , wherein the target cell is compartmentalized together with the repertoire of compounds in the microcapsules.

3. The method of claim 1 , further comprising fusing the microcapsules with second microcapsules comprising the target cells.

4. The method of claim 1 , wherein the repertoire of compounds are attached to microbeads.

5. The method of claim 4 , wherein each microbead comprises a detectable tag.

6. The method of claim 4 , wherein the repertoire of compounds are attached to microbeads through one or more cleavable linkers.

7. The method of claim 4 , further comprising releasing the compounds from the microbeads.

8. The method of claim 4 , wherein each microbead comprises one of the subsets of the repertoire of compounds represented in multiple copies.

9. The method of claim 1 , wherein the molecule associated with the target cell is an enzyme or a receptor.

10. The method of claim 9 , further comprising incubating the microcapsules.

11. The method of claim 1 , wherein the target cell is from a single cell organism.

12. The method of claim 1 , wherein the target cell is from a multicellular organism.

13. The method of claim 1 , wherein each of the repertoire of compounds comprises a detectable tag.

14. The method of claim 1 , wherein the immiscible fluid comprises a fluorocarbon oil.

15. The method of claim 1 , wherein the molecule associated with the target cell is a gene, and wherein at least one compound from the repertoire of compounds expresses or inhibits expression of a gene.

Assignees

• Harvard College
• Medical Res Council
• Res & Innovation Uk

Inventors

• Griffiths Andrew David
• Weitz David A
• Link Darren Roy
• Ahn Keunho
• Bibette Jerome

Classifications

• B01L3/502761

  specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules · CPC title

• G01N2021/6439

  with indicators, stains, dyes, tags, labels, marks · CPC title

• G01N2500/10

  involving cells · CPC title

• G01N33/5008

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title

• B01J2219/00596

  Solid-phase processes · CPC title